An in vivo transient cerebral I/R study demonstrated that andrographolide derivative CX-10 induced Nrf2 expression, down-regulated the expression of inducible nitric oxide synthase (iNOS), thus exhibited neuroprotective effects, including reduced cerebral infarction and improved neurological impairment [66]. The gene discussed is NFE2L2; the disease is brain infarction.